Mohammad Hirmand
Overview
Mohammad Hirmand received an average of $4M in total compensation, including $312K in salary, at Turning Point Therapeutics from 2019 to 2021.
Source: SEC filing on April 29, 2022.
Related executives
We found six more executives who work or worked at Turning Point Therapeutics.
Athena Countouriotis
Turning Point Therapeutics
Chief Executive Officer
Annette North
Turning Point Therapeutics
General Counsel
Paolo Tombesi
Turning Point Therapeutics
Chief Financial Officer
Siegfried PHD
Turning Point Therapeutics
Chief Scientific Officer
Yi Larson
Turning Point Therapeutics
Chief Financial Officer
Brian Baker
Turning Point Therapeutics